With the range of psychotropic drugs expanding and the usages of existing medications diversifying, we are pleased to present this very latest edition of what has become the indispensable formulary in psychopharmacology. This new edition features seven new compounds as well as information about several new formulations of existing drugs. In addition, many important new indications are covered for existing drugs, as are updates to the profiles of the entire content and collection, including an expansion of the sections on long-acting injectable formulations of antipsychotics. With its easy-to-use, template-driven navigation system, Prescriber's Guide combines evidence-based data with clinically informed advice to support everyone who is prescribing in the field of mental health.
Now established as the indispensable formulary in psychopharmacology, this latest edition of The Prescriber's Guide has been completely revised and updated to reflect the most current practice in the use of psychotropic drugs. Easy to navigate and easy to use, The Prescriber's Guide combines evidence-based information with clinically informed guidance to support clinicians in making the most effective prescribing decisions for the good of their patients. With coverage of twelve brand-new drugs – including antidepressants, antipsychotics, hypnotics, nonstimulants for ADHD and medical foods – and incorporating information on the newest indications, new formulations, new recommendations and new safety data, this edition continues to provide the essential practical support required by anyone prescribing in the field of mental health.
This is a spin-off from Stephen M. Stahl's new, completely revised and updated version of his much-acclaimed Prescriber's Guide, covering drugs to treat depression.
The revised 13th edition of the essential reference for the prescribing of drugs for patients with mental health disorders The revised and updated 13th edition of The Maudsley Prescribing Guidelines in Psychiatry provides up-to-date information, expert guidance on prescribing practice in mental health, including drug choice, treatment of adverse effects and how to augment or switch medications. The text covers a wide range of topics including pharmacological interventions for schizophrenia, bipolar disorder, depression and anxiety, and many other less common conditions. There is advice on prescribing in children and adolescents, in substance misuse and in special patient groups. This world-renowned guide has been written in concise terms by an expert team of psychiatrists and specialist pharmacists. The Guidelines help with complex prescribing problems and include information on prescribing psychotropic medications outside their licensed indications as well as potential interactions with other medications and substances such as alcohol, tobacco and caffeine. In addition, each of the book’s 165 sections features a full reference list so that evidence on which guidance is based can be readily accessed. This important text: Is the world’s leading clinical resource for evidence-based prescribing in day-to-day clinical practice and for formulating prescribing policy Includes referenced information on topics such as transferring from one medication to another, prescribing psychotropic medications during pregnancy or breastfeeding, and treating patients with comorbid physical conditions, including impaired renal or hepatic function. Presents guidance on complex clinical problems that may not be encountered routinely Written for psychiatrists, neuropharmacologists, pharmacists and clinical psychologists as well as nurses and medical trainees, The Maudsley Prescribing Guidelines in Psychiatry are the established reference source for ensuring the safe and effective use of medications for patients presenting with mental health problems.
This is a text for nursing and medical practitioners who are learning how to diagnose and treat mental disorders with medication. Skills-based, it focuses on key issues such as how to start and stop medication, how to dose and when to change medication.
Depression, anxiety and other quality of life challenges are common in people with cancer, though few oncology practices have dedicated psychiatric consultants familiar with the nuances of psycho-oncology. Written from the combined perspectives of a prescriber and non-prescriber, Psychopharmacology in Cancer Care intends to bridge this common gap in specialized care to facilitate the improved psychotropic treatment of emotional distress in cancer patients. Non-prescribers will learn to observe for potential indications for psychopharmacological interventions, make timely referrals, and monitor the benefits and side effects of medications. Prescribers will benefit from diagnostic and clinical pearls geared towards the unique symptoms and comorbidities of cancer patients. Presented in a digestible format with case reports highlighted throughout, this book will enable non-prescribers and prescribers alike to recognize and discuss the overlap of physical and emotional situations in people with cancer more clearly.